U.S. Health and Human Services (HHS) announces the launch of a first-of-its-kind national hotline to connect people with disabilities to information and services to improve access to COVID-19 vaccines.
About the Disability Information and Access Line (DIAL)
The Disability Information and Access Line (DIAL) is now available to help people with disabilities find vaccination locations in their communities, assist callers with making vaccination appointments, and connect callers to local services – such as accessible transportation – to overcome barriers to vaccination. The hotline also can provide information and resources to answer questions and address concerns about the vaccines and can connect callers to information and services that promote independent living and address fundamental needs, such as food, housing, and transportation.
About the Administration for Community Living
The Administration for Community Living was created around the fundamental principle that older adults and people of all ages with disabilities should be able to live where they choose, with the people they choose, and with the ability to participate fully in their communities. By funding services and supports provided by networks of community-based organizations, and with investments in research, education, and innovation, ACL helps make this principle a reality for millions of Americans.
About the CDC’s National Center on Birth Defects and Developmental Disabilities
The National Center on Birth Defects and Developmental Disabilities strives to advance the health and well-being of our nation’s most vulnerable populations. NCBDDD’s work is broad and far-reaching, and includes four areas of focus: saving babies through surveillance, research, and prevention of birth defects and infant disorders; helping children live to the fullest by understanding developmental disabilities; protecting people by preventing the complications of blood disorders; improving the health of people living with disabilities.
For more information, visit ACL.gov/COVID-19.